1. Home
  2. SIF vs TLSA Comparison

SIF vs TLSA Comparison

Compare SIF & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SIFCO Industries Inc.

SIF

SIFCO Industries Inc.

HOLD

Current Price

$20.21

Market Cap

108.1M

Sector

Industrials

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.14

Market Cap

124.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIF
TLSA
Founded
1913
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.1M
124.0M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
SIF
TLSA
Price
$20.21
$1.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
156.7K
713.0K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
86.67
N/A
EPS
0.71
N/A
Revenue
$111,212,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.88
$0.87
52 Week High
$29.00
$2.35

Technical Indicators

Market Signals
Indicator
SIF
TLSA
Relative Strength Index (RSI) 37.00 60.44
Support Level $19.05 $1.14
Resistance Level $22.02 $1.45
Average True Range (ATR) 2.23 0.10
MACD -0.98 0.02
Stochastic Oscillator 23.32 91.81

Price Performance

Historical Comparison
SIF
TLSA

About SIF SIFCO Industries Inc.

SIFCO Industries Inc produces forgings, sub-assemblies, and machined components for the Aerospace and Energy markets. Its services include forging, heat treating, machining, surface treatment, non-destructive testing, and sub-assembly of forged components. The company manufactures envelopes and precision forgings, as well as rough and finished machined parts, serving OEMs, Tier 1 and Tier 2 suppliers, and aftermarket providers across Aerospace, Defense, Energy, and Commercial Space. Its Products are made from steel, high-temperature alloys, nickel alloys, titanium, and aluminum, and include components for aircraft and industrial gas turbine engines, airframe structures, landing gear, wheels and brakes, helicopter rotating parts, and other commercial and industrial applications.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: